Promising new clinical research offers a trusted natural option for those who suffer from disruptive leg sensations that are often missed and dismissed in diagnosis
HOBOKEN, N.J., Aug. 23, 2022 /PRNewswire/ -- New scientific findings offer hope and a natural solution to those who suffer from sensations of crawling, pulling, throbbing, aching and itching in the legs, often resulting in sleep disruption and the uncontrollable urge to move. Restless Legs Syndrome (RLS) impacts nearly 10 percent of the U.S. population and can lead to other health concerns. A new study found Pycnogenol® French maritime pine bark extract, a leading natural anti-inflammatory and circulation booster, to significantly relieve and prevent symptoms associated with Restless Legs Syndrome.
"Restless Legs Syndrome is often missed or dismissed in diagnosis, but it's a real health condition often rooted in microcirculation. Many patients feel helpless and unheard because the symptoms seem to be exaggerated or imagined. It's not in your head – it's in your legs, and this research shows there are steps you can take with a powerful natural ingredient that may help you feel better," says author and renowned natural physician, Dr. Fred Pescatore.
Frustrating symptoms can begin at any age and worsen. Most who suffer from this condition feel sensations of crawling, pulling and throbbing after long periods of sitting or lying down, such as sleeping or sitting at a desk. Moving the legs typically temporarily relieves the discomfort, but the sensations can reoccur after movement stops. Those who have Restless Legs Syndrome can also suffer from poor sleep quality, fatigue and higher stress levels, which can impact other aspects of daily life.
The study, published in Panminerva Medica, tested 45 subjects with Restless Legs Syndrome. Twenty-one (21) subjects supplemented with 150 mg of Pycnogenol® per day, while another 24 subjects followed a standard management routine in the control group. After four weeks, subjects in the Pycnogenol® group showed significant improvement in all prominent symptoms of Restless Legs Syndrome, including:
- 33 percent decrease in crawling (vs. 3 percent decrease in control group)
- 30 percent decrease in creeping (vs. 7 percent decrease in control group)
- 41 percent decrease in pulling (vs. 7 percent decrease in control group)
- 63 percent decrease in throbbing (vs. 6 percent decrease in control group)
- 72 percent decrease in aching (vs. 3 percent decrease in control group)
- 48 percent decrease in itching (vs. 10 percent decrease in control group)
- 52 percent decrease in electric shocks (vs. 17 percent decrease in control group)
- 61 percent decrease in sleep problems (vs. 16 percent decrease in control group)
Research indicates that as many as 22 percent of those with Restless Legs Syndrome also have venous insufficiency. While additional research is needed to determine the relationship between Restless Legs Syndrome and edema, this study found that 81 percent of subjects in the Pycnogenol® group improved their status of minimal edema.
Additionally, after four weeks, the need for pain managements was significantly reduced for those in the Pycnogenol® group.
"Even when Restless Legs Syndrome is properly diagnosed, medication to treat the condition includes pharmaceuticals that increase dopamine in the brain, resulting in side effects like nausea and sleepiness. Opioids or narcotic medications may be used to relieve more severe symptoms and can be extremely addictive," says Dr. Pescatore.
"Pycnogenol® is an all-natural solution. Decades of research and global market availability show this circulation booster is safe and effective and is especially recognized as an ingredient at the forefront of naturally improving blood circulation. This study now shows its effects specifically on symptoms related to Restless Legs Syndrome," said Dr. Pescatore.
To review clinical research and additional information on Pycnogenol®, visit www.pycnogenol.com. Pycnogenol® is available in more than 1,000 dietary supplements and health products worldwide.
About Pycnogenol®
Pycnogenol® is a natural plant extract originating from the bark of the maritime pine that grows along the coast of southwest France and is found to contain a unique combination of procyanidins, bioflavonoids and phenolic acids, which offer extensive natural health benefits. The extract has been widely studied for the past 40 years and has more than 450 published studies and review articles ensuring safety and efficacy as an ingredient. Today, Pycnogenol® is available in more than 1,000 dietary supplements and health products worldwide. For more information, visit www.pycnogenol.com.
About Horphag Research
Horphag Research is the exclusive worldwide distributor for Pycnogenol® (pic-noj-en-all) brand French maritime pine bark extract. Pycnogenol® is a registered trademark of Horphag Research. For its patented ingredient, Pycnogenol®, Horphag Research has been awarded the Frost & Sullivan Excellence in Research Award, Nutraceutical Business & Technology Safety & Quality Award, SupplySide West Scientific Excellence Award and The American Botanical Council's Tyler Research Award. Horphag Research has the exclusive rights to market and sell Pycnogenol® worldwide and benefits from more than 40 years of scientific research assuring the safety and efficacy of Pycnogenol® as a dietary supplement.
SOURCE Pycnogenol
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article